Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    Cost to government and society of chronic kidney disease stage 1-5: a national cohort study

    Access Status
    Fulltext not available
    Authors
    Wyld, M.
    Lee, Crystal
    Zhuo, X.
    White, S.
    Shaw, J.
    Morton, R.
    Colagiuri, S.
    Chadban, S.
    Date
    2015
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Wyld, M. and Lee, C. and Zhuo, X. and White, S. and Shaw, J. and Morton, R. and Colagiuri, S. et al. 2015. Cost to government and society of chronic kidney disease stage 1-5: a national cohort study. Internal Medicine Journal. 45 (7): pp. 741-747.
    Source Title
    Internal Medicine Journal
    DOI
    10.1111/imj.12797
    ISSN
    1444-0903
    School
    School of Public Health
    URI
    http://hdl.handle.net/20.500.11937/47057
    Collection
    • Curtin Research Publications
    Abstract

    Background: Costs associated with chronic kidney disease (CKD) are not well documented. Understanding such costs is important to inform economic evaluations of prevention strategies and treatment options. Aim: To estimate the costs associated with CKD in Australia. Methods: We used data from the 2004/2005 AusDiab study, a national longitudinal population-based study of non-institutionalised Australian adults aged ≥25 years. We included 6138 participants with CKD, diabetes and healthcare cost data. The annual age and sex-adjusted costs per person were estimated using a generalised linear model. Costs were inflated from 2005 to 2012 Australian dollars using best practice methods. Results: Among 6138 study participants, there was a significant difference in the per-person annual direct healthcare costs by CKD status, increasing from $1829 (95% confidence interval (CI): $1740–1943) for those without CKD to $14 545 (95% CI: $5680–44 842) for those with stage 4 or 5 CKD (P < 0.01). Similarly, there was a significant difference in the per-person annual direct non-healthcare costs by CKD status from $524 (95% CI: $413–641) for those without CKD to $2349 (95% CI: $386–5156) for those with stage 4 or 5 CKD (P < 0.01). Diabetes is a common cause of CKD and is associated with increased health costs. Costs per person were higher for those with diabetes than those without diabetes in all CKD groups; however, this was significant only for those without CKD and those with early stage (stage 1 or 2) CKD. Conclusion: Individuals with CKD incur 85% higher healthcare costs and 50% higher government subsidies than individuals without CKD, and costs increase by CKD stage. Primary and secondary prevention strategies may reduce costs and warrant further consideration.

    Related items

    Showing items related by title, author, creator and subject.

    • The cost of diabetes and obesity in Australia
      Lee, Crystal; Goode, B.; Nørtoft, E.; Shaw, J.; Magliano, D.; Colagiuri, S. (2018)
      © 2018, © 2018 Informa UK Limited, trading as Taylor & Francis Group. Aims: To assess and compare the direct healthcare and non-healthcare costs and government subsidies by body weight and diabetes status. Methods: The ...
    • The cost of diabetes in adults in Australia
      Lee, Crystal; Colagiuri, R.; Magliano, D.; Cameron, A.; Shaw, J.; Zimmet, P.; Colagiuri, S. (2013)
      Aims: To assess and compare costs associated with diabetes and lesser degrees of glucose intolerance in Australia. Methods: The Australian Diabetes, Obesity and Lifestyle study collected data on the use of health services ...
    • Economic implications of obesity among people with atherothrombotic disease
      Ademi, Z.; Walls, H.; Peeters, A.; Liew, D.; Hollingsworth, B.; Stevenson, C.; Steg, P.; Bhatt, D.; Reid, Christopher (2010)
      Objective:The purpose of this study was to ascertain the impact of obesity on the cost of disease management in people with or at high risk of atherothrombotic disease from a governmental perspective using a bottom-up ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.